Alkem Labs files for IPO

Alkem is engaged in branded generics, generic drugs, APIs and nutraceuticals and market its products in over 55 countries.


(Photo courtesy:

Alkem Laboratories is entering capital market with an initial public offering (IPO) of up to 1,28,53,442 equity shares of Rs 2 each offered by its shareholders. The price band is fixed in the range of Rs 1020-1050 through book building process. The offer open on December 8, 2015 and will close on December 10, 2015.

The equity shares offered through Red Herring prospectus are proposed to be listed on BSE and NSE.

The global co-ordinators and book running lead managers are Nomura Financial Advisory and Securities (I), Axis Capital, JP Morgan India and Edelweiss Financial Services. Link Intime India will be registrar to the offer.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email